Evidence map›Paper›PMID 29500098›Full record

ReviewTrends in biochemical sciences2018

SREBPs in Lipid Metabolism, Insulin Signaling, and Beyond.

Russell A DeBose-Boyd, Jin Ye

Open access · greenAbstract readReview
In one paragraph

Review in Trends in biochemical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 207 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
207citing papers in PubMed, 1 pooled it
22.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

207 citing papers in PubMed, 1 synthesis or guideline pooled it, 334 citations in OpenAlex.

  1. Effect ofInternational journal of molecular sciences · 2024
    Pooled it
  2. Trial
  3. Trial
  4. Targeted extracellular degradation of LRP8 promotes ferroptosis in cancer cells.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Impaired mTOR/SREBP1-Mediated Lipogenesis as a Mechanism of Hepatic Glycogen Accumulation in a Carnivorous Fish Model, Largemouth Bass (Micropterus salmoides).FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Leveraging Macrophage Metabolic Reprogramming for Enhanced Anti-Tumor Immunity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  14. Role of neddylation in diabetes metabolism: potential therapeutic target.Journal of diabetes and metabolic disorders · 2026
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Functional Characterization of a Signal Peptide Peptidase inInternational journal of molecular sciences · 2026
    Article
  20. Review

147 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Russell A DeBose-BoydDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9046, USA. Electronic address: Russell.DeBose-Boyd@utsouthwestern.edu.
Jin YeDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9046, USA. Electronic address: Jin.Ye@utsouthwestern.edu.
The University of Texas Southwestern Medical Center · US

Funding

TRANSCRIPTIONAL REGULATION OF LDL RECEPTOR PROMOTERP01HL020948 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI GOLDSTEIN, JOSEPH L · 1985 to 2021
$103.1M
Proteolytic activation of CREB3L1 in treating cancers and tissue fibrosisR01GM116106 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI YE, JIN · 2015 to 2018
$1.6M
Elucidation Role of UBIAD1 in Sterol-Accelerated ERAD of HMG CoA ReductaseR01GM112409 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI DEBOSE-BOYD, RUSSELL ALFRED · 2014 to 2017
$1.3M
NHLBI NIH HHS P01 HL020948NIGMS NIH HHS R01 GM112409NIGMS NIH HHS R01 GM116106
6 · The paper itself

Abstract

Sterol regulatory element-binding proteins (SREBPs) are a family of membrane-bound transcription factors that activate genes encoding enzymes required for synthesis of cholesterol and unsaturated fatty acids. SREBPs are controlled by multiple mechanisms at the level of mRNA synthesis, proteolytic activation, and transcriptional activity. In this review, we summarize the recent findings that contribute to the current understanding of the regulation of SREBPs and their physiologic roles in maintenance of lipid homeostasis, insulin signaling, innate immunity, and cancer development.

Indexed as

LipidsSignal TransductionAnimalsHomeostasisHumansImmunity, InnateNeoplasmsSterol Regulatory Element Binding ProteinsLipidsSterol Regulatory Element Binding Proteins

Identifiers

PMID29500098
PMCPMC5923433
OpenAlexW2794383917

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.